ProPhase Labs Net Worth
ProPhase Labs Net Worth Breakdown | PRPH |
ProPhase Labs Net Worth Analysis
ProPhase Labs' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ProPhase Labs' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ProPhase Labs' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ProPhase Labs' net worth analysis. One common approach is to calculate ProPhase Labs' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ProPhase Labs' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ProPhase Labs' net worth. This approach calculates the present value of ProPhase Labs' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ProPhase Labs' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ProPhase Labs' net worth. This involves comparing ProPhase Labs' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ProPhase Labs' net worth relative to its peers.
Enterprise Value |
|
To determine if ProPhase Labs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ProPhase Labs' net worth research are outlined below:
| ProPhase Labs had very high historical volatility over the last 90 days | |
| ProPhase Labs has some characteristics of a very speculative penny stock | |
| ProPhase Labs has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 6.77 M. Net Loss for the year was (49.52 M) with profit before overhead, payroll, taxes, and interest of 436 K. | |
| ProPhase Labs currently holds about 27.5 M in cash with (17.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from gurufocus.com: ProPhase Labs Announces Closing of 3 Million Senior Secured Convertible Notes Financing PRPH ... |
ProPhase Labs uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ProPhase Labs. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ProPhase Labs' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know ProPhase Labs' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ProPhase Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ProPhase Labs backward and forwards among themselves. ProPhase Labs' institutional investor refers to the entity that pools money to purchase ProPhase Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Chapin Davis Inc | 2025-06-30 | 80 K | Susquehanna International Group, Llp | 2025-03-31 | 74 K | Blackrock Inc | 2025-03-31 | 68.9 K | Jane Street Group Llc | 2025-03-31 | 48.4 K | Bp Wealth Management, Llc | 2025-03-31 | 47.7 K | State Street Corp | 2025-03-31 | 44.7 K | Bank Of New York Mellon Corp | 2025-03-31 | 37.1 K | United Capital Management Of Ks | 2025-03-31 | 34.7 K | Two Sigma Securities, Llc | 2025-03-31 | 34.4 K | Wexford Capital Lp | 2025-03-31 | 1.5 M | Vanguard Group Inc | 2025-03-31 | 408.3 K |
Follow ProPhase Labs' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 18.07 M.Market Cap |
|
Project ProPhase Labs' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.11) | (1.05) | |
| Return On Capital Employed | (1.24) | (1.18) | |
| Return On Assets | (0.84) | (0.80) | |
| Return On Equity | (7.26) | (6.89) |
When accessing ProPhase Labs' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ProPhase Labs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ProPhase Labs' profitability and make more informed investment decisions.
Evaluate ProPhase Labs' management efficiency
ProPhase Labs has return on total asset (ROA) of (0.3092) % which means that it has lost $0.3092 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.623) %, meaning that it created substantial loss on money invested by shareholders. ProPhase Labs' management efficiency ratios could be used to measure how well ProPhase Labs manages its routine affairs as well as how well it operates its assets and liabilities. The ProPhase Labs' current Return On Tangible Assets is estimated to increase to -1.05. The ProPhase Labs' current Return On Capital Employed is estimated to increase to -1.18. As of now, ProPhase Labs' Intangible Assets are increasing as compared to previous years. The ProPhase Labs' current Other Assets is estimated to increase to about 1.6 M, while Total Assets are projected to decrease to under 36.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.39 | 0.37 | |
| Tangible Book Value Per Share | (0.40) | (0.38) | |
| Enterprise Value Over EBITDA | (1.19) | (1.13) | |
| Price Book Value Ratio | 1.96 | 1.87 | |
| Enterprise Value Multiple | (1.19) | (1.13) | |
| Price Fair Value | 1.96 | 1.87 | |
| Enterprise Value | 44.1 M | 41.9 M |
Effective leadership at ProPhase Labs drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Enterprise Value Revenue 5.156 | Revenue | Quarterly Revenue Growth (0.39) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProPhase Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProPhase Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ProPhase Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ProPhase Labs time-series forecasting models is one of many ProPhase Labs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ProPhase Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ProPhase Labs Earnings per Share Projection vs Actual
ProPhase Labs Corporate Management
| Billy White | Consultant | Profile | |
| Lance Bisesar | Corporate Controller | Profile | |
| Robert Morse | Principal Controller | Profile | |
| Stu Hollenshead | Chief Officer | Profile | |
| Sergio Miralles | Executive Diagnostics | Profile | |
| Kamal Obbad | Senior Genomics | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProPhase Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.